Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 11,360
+360 (3.27%)
Oct 8, 2026, 3:30 PM KST
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 821.8 billion as of October 8, 2026. It is the 13,340th most valuable company in the world and the 345th biggest in South Korea. Its market cap has increased by 73.52% in one year.
Market Cap
821.80B
Enterprise Value
838.26B
Revenue
53.02B
Global Rank
Country Rank
#345 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 821.80B, an increase of 771.84%. That is a compound annual growth rate of 9.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 821.80B | 62.11% |
| Dec 30, 2025 | 506.94B | 89.57% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kolon TissueGene | 1.36T |
| Pharmicell | 771.65B |
| Chabiotech | 758.52B |
| Onconic Therapeutics | 675.21B |
| Hyundai Bioscience | 668.77B |
| GI Innovation | 545.81B |
| AbClon | 509.78B |
| Proteina | 489.96B |